Merck Animal Health
Safe-Guard Equine Dewormer
Safe-Guard Equine Dewormer
Couldn't load pickup availability
Safe-Guard Equine Dewormer provides safe and effective treatment and control of large strongyles, encysted early third stage, late third stage and fourth stage cyathostome larvae, small strongyles, pinworms, ascarids and arteritis caused by fourth stage larvae of strongylus vulgaris in horses. It features an apple-cinnamon taste that ensures less waste and is safe in horses, even foals and pregnant mares.
The antiparasitic action of Safe-Guard Equine Dewormer is believed to be due to the inhibition of energy metabolism in the parasite, and each gm of Safe-Guard (fenbendazole) horse worm medicine contains 25 mg of fenbendazole for effective treatment. The artificial apple cinnamon flavor makes it easy to use this horse wormer on your animals.
Safe-Guard Equine Dewormer Features & Benefits
- Works on a wide variety of parasites with a high degree of safety
- Apple-cinnamon taste horses readily accept
- Safe for the environment and for use around other farm animals and pets
Dosage:
25 gm: For foals and weanlings (less than 18 months of age) where ascarids are a common problem, the recommended dose is 4.6 mg/lb (10 mg/kg); one syringe will deworm a 550Â lb horse. For the control of large strongyles, small strongyles, and pinworms, the recommended dose is 2.3 mg/lb (5 mg/kg).
For control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, 4th stage Strongylus vulgaris larvae, the recommended dose is 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days; administer one syringe for each 550 lb body weight per day.
92 gm: Safe-Guard® Paste 10% is administered orally at a rate of 2.3 mg/lb (5 mg/kg) for the control of large strongyles, small strongyles, and pinworms. Each mark on the plunger rod corresponds to a dose of 2.3 mg/lb (5 mg/kg) for 250 lb body weight.
For foals and weanlings (less than 18 months of age) where ascarids are a common problem, the recommended dose of 4.6 mg/lb (10 mg/kg), or two marks, will deworm a 250 lb horse.
For control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cyathostome larvae, as well as 4th stage Strongylus vulgaris larvae, the recommended dose is 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days; administer two marks for each 250 lb body weight per day.
Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.
PRECAUTIONS:
Side effects associated with Safe-Guard® Paste 10% could not be established in well-controlled safety studies in horses with single doses as high as 454 mg/lb (1,000 mg/kg) and 15 consecutive daily doses of 22.7 mg/lb (50 mg/kg). Particularly with higher doses, the lethal action of fenbendazole may cause the release of antigens by the dying parasites. This phenomenon may result in either a local or systemic hypersensitivity reaction. As with any drug, these reactions should be treated symptomatically.
Safe-Guard® Paste 10% has been evaluated for safety in pregnant mares during all stages of gestation with doses as high as 11.4 mg/lb (25 mg/kg) and in stallions with doses as high as 11.4 mg/lb (25 mg/kg). No adverse effects on reproduction were detected. The recommended dose for control of 4th stage Strongylus vulgaris larvae, 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days, has not been evaluated for safety in stallions or pregnant mares.
WARNINGS: NOT FOR USE IN HUMANS. KEEP OUT OF REACH OF CHILDREN. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For customer service, adverse effects reporting, and/or a copy of the SDS, call 1-800‑211-3573. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDAVETS, or http://www.fda.gov/reportanimalae.
OTHER WARNINGS:Â Do not use in horses intended for human consumption.
Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd, prior to the use of any dewormer.
Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.
This item cannot be shipped to California.Â
Manufacturer and/or Label Information
Manufacturer and/or Label Information
Dimensions
Dimensions
Care information
Care information
Let customers speak for us
